IDH2 and central nervous system cancer: Two spatially separated specimens that showed high or low uptake in m-PET in one glioma tissue both harbored the same TP53 and ATRX mutations, which were considered to be trunk mutations of IDH-mutant astrocytomas (Supplementary Fig. S6a-c).